13
Feb
2015
How’s It Going at the Biotech Journalism Startup? Much Better Than Expected
Please subscribe and tell your friends why it’s worthwhile. Quality journalism costs money. When you subscribe to Timmerman Report at $169 per year, you reward quality independent biotech reporting, and encourage more. Subscribe Now Sign in to your account.